Juul Vaping Order Marks Latest Feat on FDA’s Tobacco To-Do List

July 6, 2022, 9:35 AM UTC

The FDA’s decision to order Juul Labs Inc.‘s vaping products off the US market is just one aspect of the agency’s ongoing, multi-pronged approach to limit negative health outcomes from tobacco use.

The agency is conducting an additional review of Juul’s application and still has to determine the fate of hundreds of other e-cigarette applications—while also carrying out its new authority to regulate synthetic nicotine. Draft product standards to ban menthol in cigarettes and cigars are poised to be finalized soon as the agency also puts together a proposal to set limits on nicotine in cigarettes.

The efforts reflect ...

Learn more about Bloomberg Law or Log In to keep reading:

Learn About Bloomberg Law

AI-powered legal analytics, workflow tools and premium legal & business news.

Already a subscriber?

Log in to keep reading or access research tools.